ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.
about
Recent advances in understanding and treating vasculitisCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitisCombined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneIntravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.New treatment options for lupus - a focus on belimumab.B Cells, Antibodies, and More.Neutrophils in animal models of autoimmune diseaseRole of neutrophils in systemic autoimmune diseasesVasculitis in 2011: the renaissance of granulomatous inflammation in AAV.Rituximab in immunologic glomerular diseases.Neutrophils come of age in chronic inflammation.Biomarkers in ANCA-associated vasculitis.B-cell-targeted therapy in adult glomerulonephritis.Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas.Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?Repeat protocol renal biopsy in ANCA-associated renal vasculitis.Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease.B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.Serum soluble levels of the transmembrane activator and calcium-modulator and cyclophilin-ligand interactor in MPO-ANCA-associated renal vasculitis.Therapeutic Management of Pediatric Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
P2860
Q26747046-16DD4350-9AD3-4092-AA11-F598F14F8A25Q27025692-C3A03FFC-A74D-4CAA-85A5-3EDBC4825350Q27027790-82799F58-3055-42DA-91B2-DA6C55ABBBA1Q28710288-2D7870A6-CEDD-43CD-9DAB-31C0CE421363Q34377832-27BF68DA-AE1E-4162-A7DE-D08A3771AB37Q34960458-A7D41BE2-2641-485A-9EE3-6A95B12976EDQ35752030-2F97A1AD-BE60-4979-A5C4-1E53348D1462Q36432935-37F7DDF6-2FE7-4961-BCAF-9DCA5AF026B3Q36902110-251C2832-1D28-41C9-96AC-753E36B3A3CCQ37690382-4E38C54B-2AE7-4DD2-BF3C-3D79171464DCQ37974494-0EC46C8D-EABF-42A6-A6D4-C5CCE9BBEA91Q37989298-584C4070-3D06-40E9-90A8-7D88C7C6601DQ38057854-FB92EB27-8A5A-4802-941C-6C9D12F3384FQ38129720-A58459E4-8082-47FB-B05E-9EA46E4DBCA9Q38159787-38DD1873-327A-4A2B-B1C5-06F47B105B8EQ38300451-D5A2FA87-D76E-41D9-80F8-37B028389734Q41061029-0FEF542D-602C-434B-9BA7-FC6C64F42C68Q41208157-F3E297D3-A604-4794-92C9-0AE25237DBFBQ42380186-477E62D6-A95B-4641-9773-2133F444EC01Q44936070-6680F526-2045-4ED7-8B47-C50A6A62B6A6Q50850119-EE7F213D-78AD-4EE8-986C-A66919DFACD6Q50897604-125DF4C2-5136-43BE-93B5-9E11BF04187DQ54025918-06F29A58-CFB0-49EE-A4E5-8ECD44BA68CDQ59160663-034675CA-37C7-400D-8DFC-4D480AA28789
P2860
ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@en
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@nl
type
label
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@en
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@nl
prefLabel
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@en
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@nl
P2093
P356
P1476
ANCA-stimulated neutrophils re ...... lly relevant cellular process.
@en
P2093
A D Salama
C O S Savage
J M Williams
M D Morgan
N J Holden
R J Pepper
P304
P356
10.1136/ARD.2011.153890
P407
P577
2011-08-21T00:00:00Z